1-(((2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carbonitrile

Catalog No. :
ACSWTC945
CAS No. :
1817633-59-2
Molecular Formula :
C18H18FN3O3
Molecular Weight :
343.36

IUPAC Name:1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carbonitrile

1-(((2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(((2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carbonitrile
IUPAC Name1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carbonitrile
Molecular FormulaC18H18FN3O3
Molecular Weight343.36
SMILESN#CC1=CC2=C(C(OC[C@H]([C@H](CC)[C@@H]3F)NC3=O)=NC=C2)C=C1OC
InChI KeyQPROWDROAKGNSG-BJJXKVORSA-N
Synonym6-Isoquinolinecarbonitrile, 1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-
CAS No.1817633-59-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSWTC945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWNAT201 route compound structure diagram
    ACWNAT2011817630-30-0 In Stock
  2. Plus
  3. ACJWMU802 route compound structure diagram
    ACJWMU8021427393-40-5 In Stock
  4. Then
  5. ACSWTC945 route product structure diagram
    ACSWTC9451817633-59-2
Inquiry

2. ACSWTC945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSWTC945 route product structure diagram
    ACSWTC9451817633-59-2
Inquiry

Comments (0)